FIELD: medicine.
SUBSTANCE: this invention relates to a means for stimulation of the differentiation of pancreatic beta-cell precursors into insulin producing and secreting beta-cells in insulin-dependent diabetes mellitus. This agent is a pegylated form of glucagon-like peptide 1 of GLP-1 (7-37).
EFFECT: ability of the means to stimulate the differentiation of pancreatic beta-cell precursors into insulin producing and secreting beta-cells.
1 dwg, 9 tbl, 7 ex
Authors
Dates
2017-11-17—Published
2016-05-26—Filed